細胞から創る新しい医療の希望
サイフューズ (Cyfuse Biomedical) (cyfusebio.com) scores 63 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, Manufacturing brands, in the 9th percentile of 17497 Healthcare brands.
サイフューズ (Cyfuse Biomedical) is a 株式会社サイフューズのオフィシャルサイトです。サイフューズは「細胞」から、新しい医療という「希望」を創出することに取り組んでいます。. 細胞を用いた独自技術で新しい医療という希望を創出する。.
| Brand Name | サイフューズ (Cyfuse Biomedical) |
|---|---|
| Domain | cyfusebio.com |
| Industry | Healthcare, Technology |
| Main Competitors | Organovo (78/100), CELLINK (BICO Group) (86/100), Aspect Biosystems (74/100), Poietis (80/100), TissUse (77/100), 3D Bioprinting Solutions, Allevi (part of 3D Systems) (89/100) |
Moz Domain Authority 39/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,018,174 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "株式会社サイフューズのオフィシャルサイトです。サイフューズは「細胞」から、新しい医療という「希望」を創出することに取り組んでいます。" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is JA-only, limiting citation in English-language AI answers.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on Instagram, Facebook; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is サイフューズ (Cyfuse Biomedical)?", Claude could identify the brand as of October 2026. Cyfuse Biomedical is a Japanese regenerative medicine company that developed a scaffold-free Bio 3D printing technology, known as the Kenzan method, which skewers cell spheroids onto fine needle arrays to build three-dimensional tissue structures without synthetic scaffolds. The Best known for Scaffold-free Bio 3D printing using the Kenzan (needle array) method for tissue engineering.
When asked "Best brands similar to サイフューズ (Cyfuse Biomedical)?", Claude would recommend サイフューズ (Cyfuse Biomedical) as of October 2026. It's a notable and fairly unique player in scaffold-free bioprinting, so it would come up in a discussion of regenerative medicine or tissue engineering companies, especially those from Japan.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
サイフューズ (Cyfuse Biomedical)'s main competitors in Healthcare: Organovo (78/100), CELLINK (BICO Group) (86/100), Aspect Biosystems (74/100), Poietis (80/100), TissUse (77/100).
Sources: Brand Analyzer scan
サイフューズ (Cyfuse Biomedical) has low AI-search visibility, scoring 19/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
サイフューズ (Cyfuse Biomedical) scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
サイフューズ (Cyfuse Biomedical) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
サイフューズ(Cyfuse Biomedical)は、再生医療分野に特化した日本の研究開発型バイオベンチャーである。独自のバイオ3Dプリンタ技術を保有し、細胞由来の三次元組織・臓器の構築を研究開発している。
同社はスフェロイド(細胞凝集塊)とバイオ3Dプリンタを組み合わせた独自のプラットフォーム技術を用いて、様々な領域の三次元組織・臓器を構築する研究開発を行っている。これにより再生医療分野での新しい治療法や医療技術の創出を目指している。
サイフューズ (Cyfuse Biomedical) scores 19/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
サイフューズ (Cyfuse Biomedical) has a weak AI-visibility profile at 19/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #2,018,174 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 39/100. In a live check, Claude could already identify サイフューズ (Cyfuse Biomedical) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to サイフューズ (Cyfuse Biomedical): Croix-Rouge canadienne (63/100), Courier Health (63/100), Datascan Pharmacy Software (63/100), Dečiji Svet (63/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.